Depressive symptomatology, anxiety and substance use in normal school students in jalisco: a cross-sectional study
DOI:
https://doi.org/10.19136/hs.a26n1.6272Abstract
Objective: To analyse the prevalence of depressive symptomatology, anxiety and consumption of psychoactive substances, as well as the associated factors in students of the Regional Centre for Normal Education (CREN in Spanish) from Ciudad Guzmán, Jalisco, Mexico.
Materials and Methods: A cross-sectional study conducted from September to October 2023 using an online survey. A census of students enrolled for the 2023–2024 school year was carried out. 538 students participated (99.4 % response rate). The symptomatology of depression was assessed using Beck Depression Inventory-II, and anxiety using the GAD-2 scale. Substance consumption embraces alcohol, conventional cigarettes, e-cigarettes, cannabis and cocaine. Logistic regression models were carried out to analyse the association between substance use and symptoms of depression and anxiety.
Results: The prevalence of symptoms of depression was 36.2 % and that of anxiety was 7.4 %. Current consumption rates were 62.8 % for alcohol, 10.6 % for conventional cigarettes, and 15.4 % for e-cigarettes. In the fitted models, current use of conventional cigarettes (AOR = 1.95; 95% CI: 1.02–3.72), use of e-cigarettes (AOR = 2.07; 95% CI: 1.17–3.68) and cannabis use in the last 12 months (RMA = 2.05; 95% CI: 1.17–3.59) were associated with a higher likelihood of depressive symptoms. No factors associated with anxiety were found.
Conclusions: The results have shown a high prevalence of depressive symptomatology and substance use amongst normal students. The associations observed suggest a need to strengthen institutional strategies for promoting mental health and preventing substance use in teacher-training institutions.
Keywords: Depressive Symptoms; Students; Use, Substance; Mental Health.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Horizonte Sanitario

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.






















